Study of Protein Argonaute
Mutations in The KRAS Gene Drive Over 90% 0f Pancreatic Cancer Protein Argonaute 2 Appears Critical For The Progression of Benign Precursor Lesions Into Pancreatic Cancer Researchers at the University
Best Practices Against COVID When Commuting or Traveling
Pancreatic Cancer News – April, 2020 Pancreatic Cancer Patients Must Consider Best Practices Against COVID-19 When Commuting or Traveling Written By Debra Gelbart In Conjunction With Dr. Erkut Borazanci With
UVA Finds Way To Improve Cancer Outcomes
University of Virginia Finds Way To Improve Cancer Outcomes Based Upon An Individual Patient’s Genes Article Based Upon Press Release University of Virginia March 30, 2020 Content May Be Edited
Study Shows A 2-Year Survival Rate of 63.7% Versus 53.5%
Improving Surgical Outcomes For Pancreatic Cancer Patients How Chemotherapy Treatment Before Surgery is Helping Survival Rates Press Release: February 20, 2020 Edited For Style and Length While researchers make strides
Uncovers New Opportunities for Targeted Treatment
THE INSTITUTE FOR CANCER RESEARCH IDENTIFY SUBTYPES 0F ADVANCED PANCREATIC CANCER Article Based on Ontario Institute for Cancer Research Press Release: January 13, 2020 Content May Be Edited For Style
Cancer Cells Secrete Signal To Turn Off Immune System Attack
Study Shows Cancer Cells’ Signal Turns Off Immune System’s Attack On Cancer Cells Pancreatic Cancer Cells Secrete Signal That Turns Off The Immune System’s Attack On Pancreatic Cancer Cells Article
Removal of ATDC Gene Will Prevent Pancreatic Cancer in Mice
REMOVAL OF ATDC GENE COMPLETELY PREVENTS PANCREATIC CANCER IN MICE New Study Led By Dr. Diane M. Simeone Discovers That Deleting The ATDC Gene in Pancreatic Cells Results in A
Lynparza Reduces The Risk of Pancreatic Cancer Progression
Lynparza FDA APPROVED FOR TREATMENT OF METASTATIC PANCREATIC CANCER Article Based On Astrazeneca Press Release: December 30, 2019 Content May Be Edited For Style and Length Lynparza reduced the risk
NEW TREATMENT STUDY TRIGGERS SELF-DESTRUCTION OF PANCREATIC CANCER CELLS IN MICE
Article Based On Tel Aviv University Press Release: December 3, 2019 Content May Be Edited For Style and Length Research Conducted On Human Pancreatic Tumors Transplanted in Mice Pancreatic cancer
FOUR GENES LINKED TO PANCREATIC CANCER SURVIVAL
Study Links Six Inherited Genetic Mutations To Increased Risk of Pancreatic Cancer Alterations in four main genes are responsible for how long patients survive with pancreatic cancer, according to a
TGen-HonorHealth Clinical Trial Shows Tumor Shrinking in 71% of Late-Stage Pancreatic Cancer Patients
The Seena Magowitz Foundation and Mattress Firm partially funded this in-process rial which demonstrates substantial patient benefit in treating one of the most aggressive of all cancers. SCOTTSDALE, Ariz. —